BCDA
Price
$2.35
Change
+$0.04 (+1.73%)
Updated
Jul 25 closing price
Capitalization
12.96M
INTI
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Capitalization
9.43M
Interact to see
Advertisement

BCDA vs INTI

Header iconBCDA vs INTI Comparison
Open Charts BCDA vs INTIBanner chart's image
BioCardia
Price$2.35
Change+$0.04 (+1.73%)
Volume$30.85K
Capitalization12.96M
Inhibitor Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$7K
Capitalization9.43M
BCDA vs INTI Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. INTI commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Buy and INTI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BCDA: $2.35 vs. INTI: $0.05)
Brand notoriety: BCDA and INTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 23% vs. INTI: 42%
Market capitalization -- BCDA: $12.96M vs. INTI: $9.43M
BCDA [@Biotechnology] is valued at $12.96M. INTI’s [@Biotechnology] market capitalization is $9.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileINTI’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • INTI’s FA Score: 0 green, 5 red.
According to our system of comparison, INTI is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 5 TA indicator(s) are bullish while INTI’s TA Score has 4 bullish TA indicator(s).

  • BCDA’s TA Score: 5 bullish, 4 bearish.
  • INTI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both BCDA and INTI are a good buy in the short-term.

Price Growth

BCDA (@Biotechnology) experienced а +5.38% price change this week, while INTI (@Biotechnology) price change was +13.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCDA($13M) has a higher market cap than INTI($9.43M). BCDA YTD gains are higher at: 7.798 vs. INTI (-8.985). INTI has higher annual earnings (EBITDA): -3.56M vs. BCDA (-8.39M). INTI has more cash in the bank: 4.32M vs. BCDA (949K). INTI has less debt than BCDA: INTI (84.3K) vs BCDA (850K). BCDA has higher revenues than INTI: BCDA (3K) vs INTI (0).
BCDAINTIBCDA / INTI
Capitalization13M9.43M138%
EBITDA-8.39M-3.56M236%
Gain YTD7.798-8.985-87%
P/E RatioN/AN/A-
Revenue3K0-
Total Cash949K4.32M22%
Total Debt850K84.3K1,008%
FUNDAMENTALS RATINGS
BCDA vs INTI: Fundamental Ratings
BCDA
INTI
OUTLOOK RATING
1..100
9335
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5255
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INTI's Valuation (55) in the null industry is somewhat better than the same rating for BCDA (90). This means that INTI’s stock grew somewhat faster than BCDA’s over the last 12 months.

INTI's Profit vs Risk Rating (100) in the null industry is in the same range as BCDA (100). This means that INTI’s stock grew similarly to BCDA’s over the last 12 months.

INTI's SMR Rating (98) in the null industry is in the same range as BCDA (100). This means that INTI’s stock grew similarly to BCDA’s over the last 12 months.

BCDA's Price Growth Rating (52) in the null industry is in the same range as INTI (55). This means that BCDA’s stock grew similarly to INTI’s over the last 12 months.

INTI's P/E Growth Rating (90) in the null industry is in the same range as BCDA (100). This means that INTI’s stock grew similarly to BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDAINTI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 28 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INN5.520.08
+1.47%
Summit Hotel Properties
FHI49.270.43
+0.88%
Federated Hermes
TROO0.77N/A
+0.44%
TROOPS
WSM180.54N/A
N/A
Williams-Sonoma
NXTT2.24-0.14
-5.88%
Next Technology Holding

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with RNAC. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+1.73%
RNAC - BCDA
85%
Closely correlated
-0.97%
CDTX - BCDA
85%
Closely correlated
-1.54%
AGEN - BCDA
85%
Closely correlated
-1.32%
NBY - BCDA
84%
Closely correlated
+3.23%
WINT - BCDA
84%
Closely correlated
-3.92%
More

INTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, INTI has been loosely correlated with TENX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INTI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
TENX - INTI
44%
Loosely correlated
-0.98%
BCDA - INTI
35%
Loosely correlated
+1.73%
ASPHF - INTI
24%
Poorly correlated
N/A
IVEVF - INTI
17%
Poorly correlated
N/A
IDRSF - INTI
6%
Poorly correlated
N/A
More